A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A9.7 KBARYx Therapeutics, Inc.Apr 11, 3:54 PM ET·0001137774-11-000058
- 8-K24.1 KBARYx Therapeutics, Inc.Mar 22, 5:58 PM ET·0001104659-11-015831
- SC 13D/A119.5 KBARYx Therapeutics, Inc.Mar 21, 11:43 AM ET·0001072613-11-000329
- 8-K23.9 KBARYx Therapeutics, Inc.Mar 11, 4:55 PM ET·0001104659-11-013921
- 8-K48.9 KBARYx Therapeutics, Inc.Mar 9, 5:28 PM ET·0001104659-11-013320
- 8-K22.3 KBARYx Therapeutics, Inc.Feb 17, 9:24 PM ET·0001104659-11-008152
- SC 13G/A60.0 KBARYx Therapeutics, Inc.Feb 11, 4:05 PM ET·0000909518-11-000073
- SC 13G/A9.0 KBARYx Therapeutics, Inc.Feb 10, 4:44 PM ET·0000053417-11-000028
- 8-K23.2 KBARYx Therapeutics, Inc.Feb 7, 5:18 PM ET·0001104659-11-005392
- SC 13G/A10.9 KBARYx Therapeutics, Inc.Jan 31, 11:33 AM ET·0001137774-11-000008
Insiders
10Tickers
No tickers on record
Addresses
business
6300 DUMBARTON CIRCLE
FREMONT, CA, 94555
mailing
6300 DUMBARTON CIRCLE
FREMONT, CA, 94555